Inhibition of HIV-1 reverse transcriptase-catalyzed DNA strand transfer reactions by 4-chlorophenylhydrazone of mesoxalic acid

被引:33
作者
Davis, WR [1 ]
Tomsho, J [1 ]
Nikam, S [1 ]
Cook, EM [1 ]
Somand, D [1 ]
Peliska, JA [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA
关键词
D O I
10.1021/bi0015764
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA strand transfer reactions occur twice during retroviral reverse transcription catalyzed by HIV-1 reverse transcriptase. The 4-chlorophenylhydrazone of mesoxalic acid (CPHM) was found to be an inhibitor of DNA strand transfer reactions catalyzed by HN-I reverse transcriptase. Using a model strand transfer assay system described previously [Davis, W. R., et al. (1998) Biochemistry 37, 14213-14221], the mechanism of CPHM inhibition of DNA strand transfer has been characterized. CPHM was found to target the RNase I-I activity of HIV-I reverse transcriptase. DNA polymerase activity was not significantly affected by CPHM; however, it did inhibit the polymerase-independent RNase H activity with an IC50 of 2.2 muM. In the absence of DNA synthesis, CPHM appears to interfere with the translocation, or repositioning, of RT on the RNA DNA template duplex, a step required for efficient RNA hydrolysis by RNase H. Enzyme inhibition by CPHM was found to be highly specific for HIV-1 reverse transcriptase; little or no inhibition of DNA strand transfer or DNA polymerase activity was observed with MLV or AMV reverse transcriptase, T7 DNA polymerase, or DNA polymerase I. Examination of additional 4-chlorophenylhydrazones showed that the dicarboxylic acid moiety of CPHM is essential for activity, suggesting its important role for enzyme binding. Consistent with the role of the dicarboxylic acid in inhibitor function, Mg2+ was found to chelate directly to CPHM with a K-d Of 2.4 mM. Together, these studies suggest that the inhibitor may function by binding to enzyme-bound divalent metal cofactors.
引用
收藏
页码:14279 / 14291
页数:13
相关论文
共 67 条
  • [1] TRANSACTIVATION OF THE MINUS-STRAND DNA TRANSFER BY NUCLEOCAPSID PROTEIN DURING REVERSE TRANSCRIPTION OF THE RETROVIRAL GENOME
    ALLAIN, B
    LAPADATTAPOLSKY, M
    BERLIOZ, C
    DARLIX, JL
    [J]. EMBO JOURNAL, 1994, 13 (04) : 973 - 981
  • [2] Role of post-transcriptional modifications of primer tRNALys,3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription
    Auxilien, S
    Keith, G
    Le Grice, SFJ
    Darlix, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) : 4412 - 4420
  • [3] Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone
    Borkow, G
    Fletcher, RS
    Barnard, J
    Arion, D
    Motakis, D
    Dmitrienko, GI
    Parniak, MA
    [J]. BIOCHEMISTRY, 1997, 36 (11) : 3179 - 3185
  • [4] Mutations in HIV reverse transcriptase which alter RNase H activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein
    Cameron, CE
    Ghosh, M
    LeGrice, SFJ
    Benkovic, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) : 6700 - 6705
  • [5] Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template
    Canard, B
    Sarfati, R
    Richardson, CC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11279 - 11284
  • [6] DIVALENT-CATION MODULATION OF THE RIBONUCLEASE FUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    CIRINO, NM
    CAMERON, CE
    SMITH, JS
    RAUSCH, JW
    ROTH, MJ
    BENKOVIC, SJ
    LEGRICE, SFJ
    [J]. BIOCHEMISTRY, 1995, 34 (31) : 9936 - 9943
  • [7] DARLIX JL, 1993, CR ACAD SCI III-VIE, V316, P763
  • [8] FIRST GLIMPSES AT STRUCTURE-FUNCTION-RELATIONSHIPS OF THE NUCLEOCAPSID PROTEIN OF RETROVIRUSES
    DARLIX, JL
    LAPADATTAPOLSKY, M
    DEROCQUIGNY, H
    ROQUES, BP
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1995, 254 (04) : 523 - 537
  • [9] Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant
    Das, K
    Ding, JP
    Hsiou, Y
    Clark, AD
    Moereels, H
    Koymans, L
    Andries, K
    Pauwels, R
    Janssen, PAJ
    Boyer, PL
    Clark, P
    Smith, RH
    Smith, MBK
    Michejda, CJ
    Hughes, SH
    Arnold, E
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1996, 264 (05) : 1085 - 1100
  • [10] CRYSTAL-STRUCTURE OF THE RIBONUCLEASE-H DOMAIN OF HIV-1 REVERSE-TRANSCRIPTASE
    DAVIES, JF
    HOSTOMSKA, Z
    HOSTOMSKY, Z
    JORDAN, SR
    MATTHEWS, DA
    [J]. SCIENCE, 1991, 252 (5002) : 88 - 95